4
Microneedle Drug Delivery Patches, Syringes & Systems Devices, Players, Markets and Forecasts Report Prospectus Greystone Research associates

Microneedle Drug Delivery Patches & Syringes Report Prospectus

Embed Size (px)

DESCRIPTION

Microneedle technology is attaining commercial viability at a time when drug developers are faced with new challenges as they assess ways to administer new classes of compounds with significant therapeutic potential. The widespread availability of rapid throughput screening is accelerating the discovery of new drugs, a significant number of which are large-molecule therapeutic compounds that cannot tolerate passage through the digestive system, requiring pharmaceutical companies to forego oral formulations and select alternate routes of administration.

Citation preview

Page 1: Microneedle Drug Delivery Patches & Syringes Report Prospectus

Microneedle Drug Delivery Patches,

Syringes & Systems

Devices, Players, Markets

and Forecasts

Report Prospectus

Greystone Research

associates

Page 2: Microneedle Drug Delivery Patches & Syringes Report Prospectus

Greystone Research Associates is pleased to announce the publication of a new market study. Microneedle Drug Delivery Patches, Syringes & Systems: Devices, Players, Markets and Forecasts is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector.

The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, healthcare segments and commercial opportunities for microneedle arrays and devices in the delivery of therapeutic drugs. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Converging Technology that Addresses Unmet Medical Needs

Microneedle technology is attaining commercial viability at a time when drug developers are faced with new challenges as they assess ways to administer new classes of compounds with significant therapeutic potential. The widespread availability of rapid throughput screening is accelerating the discovery of new drugs, a significant number of which are large-molecule therapeutic compounds that cannot tolerate passage through the digestive system, requiring pharmaceutical companies to forego oral formulations and select alternate routes of administration.

Microneedle technology has the potential address the growing trend toward self-administration by allowing the precise placement of therapeutic agents at prescribed locations below the skin. But before microneedles find widespread use, developers must refine the techniques for large-scale manufacturing and for optimally inserting microneedles into the skin, and advance the design integration of microneedles into commercially viable drug delivery systems.

Managed Care Managers

Management Consultants

Financial Analysts

Product Developers

Component Suppliers

CMOs, CSOs

Pharma Product Managers

Device Suppliers

Biotech Managers

Drug Marketers

& Strategists Clinical

Managers

Drug Distributors

Pharma Regulators

Report Value Matrix

Mic

ro

ne

ed

le D

rug

De

liv

ery

Pa

tch

es

, S

yr

ing

es

& S

ys

tem

s

Page 3: Microneedle Drug Delivery Patches & Syringes Report Prospectus

Executive Summary

Microneedle Medical Market Overview Drug Delivery & Self-Administration Chronic Conditions & Dosing Frequency Patient Safety and Compliance Microneedle Market Drivers The Trend to Minimally Invasive Medicine Shifting Patient Demographics Managed Care Initiatives Government Technology Transfer Programs

Microneedle Design & Technology Microneedle Form Factors Solid Microneedles Hollow Microneedles Coated Microneedles Dissolvable Microneedles Microneedle Arrays & Array Geometries Microneedle Manufacturing Material Selection Issues Fabrication Techniques Emerging Fabrication Methods

Medical Microneedles – Assessments & Commercialization Prospects

Solid Microneedle Arrays BA058 Patch ClickSoft DrugMAT Functional Microarray (FMA) MicroCor Micropatch Micropoint Patch sMTS ZP Patch Hollow Microneedle Arrays hMTS Transderm Micro-Trans Silicon Microneedles OnVax Phase Transition Microneedle Patch Dissolving Microneedle Chip Syringe Mounted Microneedles AdminPatch MicronJet NanoJect Soluvia Programmable Microneedle Patch

Near-Terms Markets - Sector Assessments and Forecasts

Dermatology/Cosmetic Surgery Genetic/DNA/Nucleotide Therapeutics Osteoporosis Reproductive Medicine Vaccines

Company Profiles

Table of Contents

Page 4: Microneedle Drug Delivery Patches & Syringes Report Prospectus

Ordering Information

Orders may be placed via postal mail, e-mail or fax. Orders not accompanied by a purchase order must contain a

telephone number for verification, and clearly indicate the physical shipping address. Orders which are not prepaid must

indicate the billing address. There is no charge for handling and shipping for destination addresses within the continental US.

Payment

We accept the following forms of payment:

Company Check: Please make checks payable to ‘Greystone Associates’

Credit Cards: We accept MasterCard, Visa and American Express

Wire Transfers: See ’Wire Transfers’ below for more information

Orders Outside the U.S.

Orders must be prepaid via credit card, company check in US funds and drawn on a US bank, or wire transfer. There is a $50

per copy shipping and handling charge for international shipments.

Wire Transfers: TD Banknorth

300 Franklin Street

Manchester, NH 03103

(Call for Account Information)

Mailing Address: Greystone Research Associates

Client Services

P.O. Box 1362

Amherst, NH 03031

How To Order

98 Route 101A • P .O. Box 1362 • Amherst, NH 03031 • 603-595-4340 • (F) 603-218-7020 • [email protected]

Microneedle Drug Delivery Patches, Syringes & Systems: Devices, Players, Markets and Forecasts

Select Format Price (U.S. funds) Total

Electronic $2,850.00

Site License $4,850.00

Enterprise License $6,500.00

Total Payment (U.S. funds)

Method of Payment: ___ Company Check ___ ___ ___ ___ Wire Transfer (International) Card Number:___________________________ Name on Card ________________________________________

Expiration Date: ____________ Card CVV_______ Signature___________________________________

Billing Information Shipping Information

Click here if same as Billing Information

Name: Name:

Title: Title:

Company: Company:

Street Address: Street Address:

City,State/Province: City,State/Province:

Country/Postal Code: Country/Postal Code:

Phone: Phone:

Fax: Fax:

Email: Email:

98 Route 101A • P .O. Box 1362 • Amherst, NH 03031 • 603-595-4340 • (F) 603-218-7020 • [email protected]